INOPERABLE DISEASE

Clinical trials for INOPERABLE DISEASE explained in plain language.

Never miss a new study

Get alerted when new INOPERABLE DISEASE trials appear

Sign up with your email to follow new studies for INOPERABLE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3

New combo therapy aims to outsmart resistant melanoma

Disease control Recruiting now

This study is for people with advanced melanoma (stage III or IV that cannot be removed by surgery) whose cancer has stopped responding to standard immunotherapy drugs like nivolumab or pembrolizumab. The trial tests a new sequence of three drugs: high-dose interleukin-2 (IL2) pl…

Matched conditions: INOPERABLE DISEASE

Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated May 04, 2026 16:31 UTC

INOPERABLE DISEASE

Get alerted when new INOPERABLE DISEASE trials appear

New combo therapy aims to outsmart resistant melanoma